What is it about?
Improvement to, and maintenance of, a low-risk profile (<5% mortality/year) is the current goal of treatment strategies in patients with pulmonary arterial hypertension. We have identified and tested cardiac MRI thresholds to risk stratify patients at baseline and at follow-up. Cardiac MRI when used as a sole risk stratification tool can identify a high percentage of patients at low-risk of one-year mortality and when used in conjunction with current risk stratification approaches can improve risk stratification.
Featured Image
Read the Original
This page is a summary of: Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension, American Journal of Respiratory and Critical Care Medicine, February 2020, American Thoracic Society,
DOI: 10.1164/rccm.201909-1771oc.
You can read the full text:
Contributors
The following have contributed to this page